Sabrina Islam, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, offered insight to Reuters Health about a study published in the journal BMJ examining patient-level data of antidiabetic medication rosiglitazone and its association with increased cardiovascular risks. Dr. Islam was not involved in the study. MD Alert picked up the Reuters Health article.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH